Trial · NCT02510261
Results by group180
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 180
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Adverse Events (AEs) Leading to Study Discontinuation | Prior Placebo Group of Study 004 | 49.0 | percentage of participants | ||
| Percentage of Participants With Adverse Events (AEs) Leading to Study Discontinuation | Prior Patisiran Group of Study 004 | 16.8 | percentage of participants | ||
| Percentage of Participants With Adverse Events (AEs) Leading to Study Discontinuation | Prior Patisiran Group of Study 003 | 0.0 | percentage of participants | ||
| Change From Baseline in the Total Neuropathy Impairment Score (NIS) at Year 5 | Prior Placebo Group of Study 004 | Baseline | 81.47 | Standard Deviation 41.674 | score on a scale |
| Change From Baseline in the Total Neuropathy Impairment Score (NIS) at Year 5 | Prior Patisiran Group of Study 004 | Baseline | 62.26 | Standard Deviation 37.875 | score on a scale |
| Change From Baseline in the Total Neuropathy Impairment Score (NIS) at Year 5 | Prior Patisiran Group of Study 003 | Baseline | 35.48 | Standard Deviation 28.686 | score on a scale |
| Change From Baseline in the Total Neuropathy Impairment Score (NIS) at Year 5 | Prior Placebo Group of Study 004 | Change From Baseline at Year 5 | 11.45 | Standard Deviation 16.566 | score on a scale |
| Change From Baseline in the Total Neuropathy Impairment Score (NIS) at Year 5 | Prior Patisiran Group of Study 004 | Change From Baseline at Year 5 | 10.72 | Standard Deviation 13.654 | score on a scale |
| Change From Baseline in the Total Neuropathy Impairment Score (NIS) at Year 5 | Prior Patisiran Group of Study 003 | Change From Baseline at Year 5 | 11.18 | Standard Deviation 17.554 | score on a scale |
| Change From Baseline in the Total Modified NIS (mNIS +7) Composite Score At Year 3 | Prior Placebo Group of Study 004 | Baseline | 101.07 | Standard Error 43.774 | score on a scale |
| Change From Baseline in the Total Modified NIS (mNIS +7) Composite Score At Year 3 | Prior Patisiran Group of Study 004 | Baseline | 74.72 | Standard Error 42.584 | score on a scale |
| Change From Baseline in the Total Modified NIS (mNIS +7) Composite Score At Year 3 | Prior Patisiran Group of Study 003 | Baseline | 45.66 | Standard Error 31.640 | score on a scale |
| Change From Baseline in the Total Modified NIS (mNIS +7) Composite Score At Year 3 | Prior Placebo Group of Study 004 | Change From Baseline at Year 3 | -6.69 | Standard Error 3.389 | score on a scale |
| Change From Baseline in the Total Modified NIS (mNIS +7) Composite Score At Year 3 | Prior Patisiran Group of Study 004 | Change From Baseline at Year 3 | 8.07 | Standard Error 1.874 | score on a scale |
| Change From Baseline in the Total Modified NIS (mNIS +7) Composite Score At Year 3 | Prior Patisiran Group of Study 003 | Change From Baseline at Year 3 | 5.46 | Standard Error 2.450 | score on a scale |
| Change From Baseline in the NIS+7 Total Score at Week 52 | Prior Placebo Group of Study 004 | Baseline | 98.42 | Standard Error 42.281 | score on a scale |
| Change From Baseline in the NIS+7 Total Score at Week 52 | Prior Patisiran Group of Study 004 | Baseline | 78.74 | Standard Error 39.417 | score on a scale |
| Change From Baseline in the NIS+7 Total Score at Week 52 | Prior Patisiran Group of Study 003 | Baseline | 49.66 | Standard Error 31.319 | score on a scale |
| Change From Baseline in the NIS+7 Total Score at Week 52 | Prior Placebo Group of Study 004 | Change From Baseline at Week 52 | 1.44 | Standard Error 2.061 | score on a scale |
| Change From Baseline in the NIS+7 Total Score at Week 52 | Prior Patisiran Group of Study 004 | Change From Baseline at Week 52 | 1.49 | Standard Error 0.894 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02510261/results